期刊文献+

作用于AT2受体化合物的研究进展

Review of novel compounds that act on the AT receptor
原文传递
导出
摘要 血管紧张素Ⅱ 2型受体(angiotensin receptor type 2, AT2R)是血管紧张素Ⅱ (angiotensin Ⅱ, Ang Ⅱ)受体亚型之一,选择性激动或拮抗AT2受体可引起血管舒张、抗细胞增殖、促突起生长、阻断神经元兴奋性等。AT2受体可作为潜在的药物靶标用于心血管疾病、纤维化、炎症、神经元疾病和肿瘤等疾病的治疗。新型选择性作用于AT2受体的药物研发以及AT2受体参与的细胞内信号转导机制的研究是一个具有挑战性但值得深入研究的领域。本文对AT2受体蛋白的研究进展以及作用于AT2受体化合物的研究进行阐述,结合构效关系分析,为该领域进一步的研究提供借鉴和指导。 Selective activation or inhibition of the angiotensin Ⅱ type 2(AT2) receptor can cause vasodilation,decrease cell proliferation, promote neurite outgrowth and block neuronal excitability. The AT2 receptor can be used as a potential drug target for the treatment of cardiovascular diseases, fibrosis, inflammation, neuronal diseases and tumors. Research and development of new drugs that selectively act on the AT2 receptor and the mechanism of intracellular signal transduction involving the AT2 receptor is a challenging but worthy endeavor. We review research progress on the AT2 receptor and compounds that act on the AT2 receptor, along with structure-activity relationship analysis, to provide reference and guidance for further research in this field.
作者 张艳春 张祖志 徐进宜 王丹慧 徐梅月 ZHANG Yan-chun;ZHANG Zu-zhi;XU Jin-yi;WANG Dan-hui;XU Mei-yue(College of Pharmacy,Anhui University of Chinese Medicine,Hefei 230012,China;Anhui Province Key Laboratory of Chinese Medicinal Formula,Hefei 230012,China;School of Pharmacy,China Pharmaceutical University,Nanjing 210009,China)
出处 《药学学报》 CAS CSCD 北大核心 2021年第3期711-722,共12页 Acta Pharmaceutica Sinica
基金 安徽省自然科学基金面上项目(1908085MH269)。
关键词 血管紧张素Ⅱ2型受体 激动剂 拮抗剂 选择性 构效关系 angiotensin receptor type 2 receptor agonist antagonist selectivity structure and activity relationship
  • 相关文献

参考文献1

二级参考文献24

  • 1Carey R M. Update on the role of the AT2 receptor [ J ]. Curr Opin Nephrol Hypertens,2005 ,14 ( 1 ) :67-71.
  • 2Steckelings U M,Kaschina E,Unger T. The AT2 receptor- A matter of love and hate [ J ]. Pepticles. 2005,26 ( 8 ) :1401-1409.
  • 3Wendy W, Batenburg M, Ingrid M, et al. Angiotensin Ⅱtype 2 receptor-mediated vasodilation in human coronary mieroarteries[ J]. Circular ,2004 , 109 (19) :2296-2301.
  • 4Jones E S, Black M J, Widdop R E. Angiotensin ATereceptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade[J ]. J Mol Cell Cardiol,2004,37(5 ) : 1023-1030.
  • 5AbdAlla S, Hentz L, Abdel-tawab A M, et al. The angio-tensin I1 AT2 receptor is an AT1 receptor antagonist[J]. J Biol Chem,2001,276 (43) : 39721-39726.
  • 6Miura S, Matsuo Y, Kiya Y, et al. Molecular mechanisms of the antagonistic action between AT: and AT2 receptors [ J]. Biochem Biophy Res ,2010 ,391 ( 1 ) :85-90.
  • 7Pavel J, Terr6n J A, Benicky J, et al. Increased Angioten- sin 11 AT: receptor mRNA and binding in spleen andlung of ATz receptor gene disrupted mice[ J ]. Regul Pept, 2009,158 (1/3) : 156-166.
  • 8Deraet M, Pdhakova L, Boucard A J, et al. Angiotensin Ⅱ is bound to both receptors ATj and AT2, parallel to thetransmembrane domains and in an extended form[ J]. Can J Physiol Pharmacol,2002,80(5):418-425.
  • 9Sko1d C, Nikiforovich G, Karle'n A. Modeling binding modes of angiotensinⅡ and pseudopeptide analogues to the AT: receptor[ J]. J Mol Graph Model,2008,26(6) :991-1003.
  • 10Lindman S,Lindeberg G,Frandberg P,et al Effect of 3-5monocyclizations of angiotensin Ⅱ and 4-aminoPhe6-Ang II on AT2 receptor affinity [ J ]. Bioorg Med Chem, 2003, 11 (13) :2947-2954.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部